Dr. Johnson studied at the University of Notre Dame and SUNY Upstate Medical University. He completed General Surgery and Plastic Surgery residencies at Case-Western Reserve University and the University of Pittsburgh, respectively. Afterwards, he took a postdoctoral fellowship in thrombosis/platelet biology at Harvard University.

        Dr. Johnson practiced reconstructive surgery for ten years at the University of Pittsburgh, where he founded and led the Pittsburgh Tissue Engineering Initiative. Subsequently, he then co-founded and was the CEO of Tissue Informatics, Inc. He has held various positions that include Chief Medical Officer, Executive Vice President of Life Sciences and Chief Business Officer of Icoria, Inc. and Executive Vice President at Entegrion, Inc. Dr. Johnson is a past Chairperson of the Plastic Surgery Research Council, President of the Pennsylvania Biotechnology Association and Tissue Engineering Society International, and is currently the Co-Editor-in-Chief of the three –part journal, Tissue Engineering. He serves on the Board of Trustees of the Pittsburgh Tissue Engineering Initiative, Renacyte, LLC, and the University of North Carolina Medical Foundation as well. He also serves as the National Chairman of the University of North Carolina at Chapel Hill School of Medicine Medical Excellence Fund. Given his extensive training and experience, Dr. Johnson is now the Vice President of Research and Development at Avery Dennison Medical and President and CEO of Scintellix, LLC, a biomedical consultancy based in Raleigh, NC.